An inverse association between ovarian cysts and breast cancer in the Breast Cancer Family Registry

International Journal of Cancer

Volumn 118, Issue 1, 2006, Pages 197-202

  Knight, Julia A ^a   John, Esther M ^b   Milne, Roger L ^c   Dite, Gillian S ^c   Balbuena, Ron ^d   Shi, Ellen J Q ^e   Giles, Graham G ^f   Ziogas, Argyrios ^d   Andrulis, Irene L ^a,e   Whittemore, Alice S ^g   Hopper, John L ^c  

^a MOUNT SINAI HOSPITAL   (Canada)

^b NORTHERN CALIFORNIA CANCER CENTER   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CANCER CARE ONTARIO   (Canada)

^f CANCER EPIDEMIOLOGY CENTRE   (Australia)

^g STANFORD UNIVERSITY   (United States)

Author keywords

Breast cancer; Case control study; Etiology; Ovarian cysts

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; BREAST CANCER; CANADA; CANCER REGISTRY; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY CYST; OVARY POLYCYSTIC DISEASE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; UNITED STATES;

ADOLESCENT; ADULT; AGED; AUSTRALIA; BREAST NEOPLASMS; CALIFORNIA; CASE-CONTROL STUDIES; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; ODDS RATIO; ONTARIO; OVARIAN CYSTS; REGISTRIES; RISK ASSESSMENT;

EID: 27944496042     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.21298     Document Type: Article

References (37)

1. Homburg R. What is polycystic ovarian syndrome? A proposal for a consensus on the definition and diagnosis of polycystic ovarian syndrome. Hum Reprod 2002;17:2495-9.
2. Guznick DS. Polycystic ovary syndrome. Obstet Gynecol 2004;103:181-93.
3. Vignali M, Infantino M, Matrone R, Chiodo I, Somigliana E, Busacca M, Viganò P. Endometriosis: novel etiopathogenetic concepts and clinical perspectives. Fertil Steril 2002;78:665-78.
4. Holt VL, Cushing-Haugen KL, Daling JR. Oral contraceptives, tubal sterilization, and functional ovarian cyst risk. Obstet Gynecol 2003;102:252-8.
5. The ESHRE Capri Workshop Group. Ovarian and endometrial function during hormonal contraception. Hum Reprod 2001;16:1527-35.
6. Thakur A, Yang I, Lin A, Buchmiller-Crair T, Fonkalsrud EW. Management of ovarian cysts in women undergoing restorative proctolectomy for ulcerative colitis. Amer Surgeon 2003;69:339-42.
7. Belgorosky A, Pepe C, Marino R, Guercio G, Saraco N, Vaiani E, Rivarola MA. Hypothalamic-pituitary-ovarian axis during infancy, early and late prepuberty in an aromatase-deficient girl who is a compound heterozygote for two new point mutations of the CYP19 gene. J Clin Endocrinol Metab 2003;88:5127-31.
8. Conte FA, Grumbach MM, Ito Y, Fisher CR, Simpson ER. A syndrome of female pseudohermaphrodism, hypergoandotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). J Clin Endocrinol Metab 1994;78:1287-92.
9. Plouffe L Jr, Siddhami S. The effect of selective estrogen receptor modulators on parameters of the hypothalamic-pituitary-gonadal axis. Ann NY Acad Sci 2001;949:251-8.
10. Mourits MJE, De Vries EGE, Willemse PHB, Ten Hoor KA, Hollema H, Van der Zee AGJ. Tamoxifen treatment and gynecologic side effects: a review. Obstet Gynecol 2001;97:855-66.
11. Koivunen RM, Juutinen J, Vauhkonen I, Morin-Papunen LC, Ruokonen A, Tapanainen JS. Metabolic and steroidogenic alterations related to increased frequency of polycystic ovaries in women with a history of gestational diabetes. J Clin Endocrinol Metab 2001;86:2591-9.
12. Kousta E, Cela E, Lawrence NJ, Penny A, Millauer BA, White DM, Wilson H, Robinson S, Johnston DG, McCarthy MI, Franks S. The prevalence of polycystic ovaries in women with a history of gestational diabetes. Clin Endocrinol 2000;52:501-7.
13. Anttila L, Karjala K, Penttilä T-A, Ruutiainen K, Ekblad U. Polycystic ovaries in women with gestational diabetes. Obstet Gynecol 1998;92:13-6.
14. Holte J, Gennarelli G, Wide L, Lithell H, Berne C. High prevalence of polycystic ovaries and associated clinical, endocrine, and metabolic features in women with a previous gestational diabetes mellitus. J Clin Endocrinol Metab 1998;83:1143-50.
15. Van Hooff MHA, Voorhorst FJ, Kaptein MBH, Hirasing RA, Koppenaal C, Schoemaker J. Polycystic ovaries in adolescence and the relationship with menstrual cycle patterns, luteinizing hormone, androgens, and insulin. Fertil Steril 2000;74:49-58.
16. Michelmore KF, Balen AH, Dunger DB, Vessey MP. Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol 1999;51:779-86.
17. Coulam CB, Annegers JF, Kranz JS. Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol 1983;61:403-7.
18. Anderson KE, Sellers TA, Chen P-L, Rich SS, Hong C-P, Folsom AR. Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa. Cancer 1997;79:494-9.
19. Parazzini F, La Vecchia C, Franceschi S, Talamini R, Negri E, Crosignani PG. Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa. Cancer 1997;80:1360-2.
20. Gammon MD, Thompson WD. Polycystic ovaries and the risk of breast cancer. Am J Epidemiol 1991;134:818-24.
21. John EM, Hopper JL, Beck JC, Knight JA, Neuhausen SL, Senie RT, Ziogas A, Andrulis IL, Anton-Culver H, Boyd N, Buys SS, Daly MB, et al. The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res 2004;6:R375-89.
22. Hopper JL, Chenevix-Trench G, Jolley D, Dite GS, Jenkins MA, Venter DJ, McCredie MRE, Giles GG. Design and analysis issues in a population-based case-control-family-study of the genetic epidemiology of breast cancer, and the Cooperative Family Registry for Breast Cancer Studies (CFRBCS). J Natl Cancer Inst Mongr 1999;26:95-100.
23. Knight JA, Sutherland HJ, Glendon G, Boyd NF, Andrulis IL for the Ontario Cancer Genetics Network. Characteristics associated with participation at various stages at the Ontario site of the cooperative family registry for breast cancer studies. Ann Epidemiol 2002;12:27-33.
24. Dite GS, Jenkins MA, Southey MC, Hocking JS, Giles GG, McCredie MR, Venter DJ, Hopper JL. Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. J Natl Cancer Inst 2003:95:448-57.
25. Knight JA, Onay UV, Wells S, Li H, Shi EJQ, Andrulis IL, Ozcelik H. Genetic variants of GPX1 and SOD2 and breast cancer risk at the Ontario site of the Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 2004;13:146-9.
26. Weinberg C, Wacholder S. The design and analysis of case-control studies and biased sampling. Biometrics 1990;46:963-75.
27. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745-9.
28. Giudice LC, Kao LC. Endometriosis. Lancet 2004;364:1789-99.
29. Dimitrakakis C, Zhou J, Bondy CA. Androgens and mammary growth and neoplasia. Fertil Steril 2002;77(Suppl 4):S26-33.
30. Liao DJ, Dickson RB. Roles of androgens in the development, growth, and carcinogenesis of the mammary gland. J Steroid Biochem Mol Biol 2002;80:175-89.
31. Rao CV. Does full-term pregnancy at a young age protect women against breast cancer through hCG? Obstet Gynecol 2000;96:783-6.
32. Russo IH, Russo J. Hormonal approach to breast cancer prevention. J Cell Biochem 2000;34(Suppl):1-6.
33. Kreiger N, Sloan M, Cotterchio M, Kirsh V. The risk of breast cancer following reproductive surgery. Eur J Cancer 1999;35:97-101.
34. Calle E, Rodriguez C, Walker K, Thun M. Tubal sterilization and breast cancer mortality in a prospective cohort of US women. Am J Epidemiol 1999;149(Suppl):S27.
35. Shin MH, Kim DH, Lee HK, Yang JH, Choi KJ, Ahn YO. The effect of tubal ligation on the protection from breast cancer: a case-control study in Korea. Am J Epidemiol 1996;143(Suppl):S58.
36. Brinton LA, Gammon MD, Coates RJ, Hoover RN. Tubal ligation and risk of breast cancer. Br J Cancer 2000;82:1600-4.
37. Irwin KL, Lee NC, Peterson HB, Rubin GL, Wingo PA, Mandel MG and the Cancer and Steroid Hormone Study Group. Hysterectomy, tubal sterilization, and the risk of breast cancer. Am J Epidemiol 1988;127:1192-1201.